Bronchodilators Market: Increasing Growth Seen in Pharmaceuticals Sector

| July 31, 2017

article image
Bronchodilators Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The following companies as the key players in the global bronchodilators market: AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, and GlaxoSmithKline. Other Prominent Vendors in the market are: ALK-Abello, Amgen, Array BioPharma, ASMACURE, Astellas Pharma, Atopix Therapeutics, CHIESI Farmaceutici, Dynavax Technologies, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma International, Nycomed Pharma, Oxagen, Pearl Therapeutics, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, Sanofi, SolAeroMed, Stallergenes Greer, sterna biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, and Verona Pharma.

Spotlight

Sunshine Drugs Limited

An independently owned and operated retail pharmacy business; currently totaling seven local pharmacies in Windsor, Ontario (Canada): 1909 IDA, Fontainebleu, Forest Glade IDA, Moy Medical IDA, Sandwich IDA, IDA TLC, and Westminster IDA. Find us on Facebook by keywords "Sunshine Drugs".

OTHER ARTICLES

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | April 11, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 11, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | April 11, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Spotlight

Sunshine Drugs Limited

An independently owned and operated retail pharmacy business; currently totaling seven local pharmacies in Windsor, Ontario (Canada): 1909 IDA, Fontainebleu, Forest Glade IDA, Moy Medical IDA, Sandwich IDA, IDA TLC, and Westminster IDA. Find us on Facebook by keywords "Sunshine Drugs".

Events